Virbac accelerates its commercial development in the United States

Giovanni-Abruzzini-Virbac

Virbac officially announces the appointment of Giovanni Abruzzini as the new President and CEO of Virbac North America, effective from March 27, 2023. His primary objective will be to develop the company’s North American commercial activities in accordance with the overall strategy of the Virbac group. Giovanni Abruzzini, who has extensive experience in the healthcare […]